Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
More than a million children across the US have lost access to Supplemental Nutrition Assistance Program...
As the U.S. war against Iran edges past 150 days, a controversial former ally of President...
One of the most intimidating aspects of modern US relations with the Arab and Muslim world...
